Search research articles
Contact Us
Filters
Showing results (71-80 of 487) with videos related to
Page
of 49
Sort By:
Future Oncology (London, England)
|
January 10, 2015
Exceptional responders: in search of the science behind the miracle cancer cures
Ishwaria Mohan Subbiah, Vivek Subbiah
JAMA Oncology
|
March 25, 2016
Bone Complications in Patients With Cancer
Vivek Subbiah, Howard L West
Cancer Discovery
|
December 4, 2019
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway Inhibition
Vivek Subbiah, Sumanta K Pal
Molecular Cancer Therapeutics
|
February 1, 2024
Predicting the Abscopal Phenomenon-Reply
Blessie Elizabeth Nelson, Vivek Subbiah
Carcinogenesis
|
November 8, 2024
Redefining pancreatic cancer management with tumor-agnostic precision medicine
Neha K Reddy, Vivek Subbiah
Surgical Oncology Clinics of North America
|
February 24, 2024
Tissue-Agnostic Cancer Therapy Approvals
Mohamed A Gouda, Vivek Subbiah
JAMA Oncology
|
February 15, 2024
Modernize Precision Oncology With Decentralized Trial Tools
Muhammad Shaalan Beg, Vivek Subbiah
Therapeutic Advances in Medical Oncology
|
June 26, 2023
Precision oncology with selective RET inhibitor selpercatinib in <i>RET</i>-rearranged cancers
Mohamed A Gouda, Vivek Subbiah
Med (New York, N.Y.)
|
November 12, 2022
Exportin(g) precision oncology beyond genomics with XPO1 inhibition
Mohamed A Gouda, Vivek Subbiah
Pediatric Blood & Cancer
|
March 3, 2007
Modifiers of risk for infectious complications of cancer therapy in children: the long road ahead
Vivek Subbiah, Stephen J Chanock
Page
of 49
Search research articles
Search
Showing results (71-80 of 487) with videos related to
Sort By:
Page
of 49
Future Oncology (London, England)
|
January 10, 2015
Exceptional responders: in search of the science behind the miracle cancer cures
Ishwaria Mohan Subbiah, Vivek Subbiah
JAMA Oncology
|
March 25, 2016
Bone Complications in Patients With Cancer
Vivek Subbiah, Howard L West
Cancer Discovery
|
December 4, 2019
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway Inhibition
Vivek Subbiah, Sumanta K Pal
Molecular Cancer Therapeutics
|
February 1, 2024
Predicting the Abscopal Phenomenon-Reply
Blessie Elizabeth Nelson, Vivek Subbiah
Carcinogenesis
|
November 8, 2024
Redefining pancreatic cancer management with tumor-agnostic precision medicine
Neha K Reddy, Vivek Subbiah
Surgical Oncology Clinics of North America
|
February 24, 2024
Tissue-Agnostic Cancer Therapy Approvals
Mohamed A Gouda, Vivek Subbiah
JAMA Oncology
|
February 15, 2024
Modernize Precision Oncology With Decentralized Trial Tools
Muhammad Shaalan Beg, Vivek Subbiah
Therapeutic Advances in Medical Oncology
|
June 26, 2023
Precision oncology with selective RET inhibitor selpercatinib in <i>RET</i>-rearranged cancers
Mohamed A Gouda, Vivek Subbiah
Med (New York, N.Y.)
|
November 12, 2022
Exportin(g) precision oncology beyond genomics with XPO1 inhibition
Mohamed A Gouda, Vivek Subbiah
Pediatric Blood & Cancer
|
March 3, 2007
Modifiers of risk for infectious complications of cancer therapy in children: the long road ahead
Vivek Subbiah, Stephen J Chanock
Page
of 49